Research conducted by Sharma et al. in HCC has identified different subpopulations of TAMs characterized by CD163high and folate receptor beta (FOLR2) expression and other clusters of CD163low TAMs characterized by the expression of Osteopontin (SPP1) or Metallothionein 1G (MT1G). Here, FOLR2 is linked to hepatocellular carcinoma.